HEADER TRANSFERASE 16-NOV-07 3BEA TITLE CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CSF-1-R, FMS PROTO-ONCOGENE, C-FMS, CD115 ANTIGEN; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: CSF1R, FMS; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA KEYWDS KINASE DOMAIN, INHIBITOR, TRANSFERASE, JUXTAMEMBRANE DOMAIN, ATP- KEYWDS 2 BINDING, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, RECEPTOR, KEYWDS 4 TRANSMEMBRANE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR C.SCHUBERT REVDAT 5 30-AUG-23 3BEA 1 REMARK REVDAT 4 20-OCT-21 3BEA 1 REMARK SEQADV REVDAT 3 02-AUG-17 3BEA 1 SOURCE REVDAT 2 24-FEB-09 3BEA 1 VERSN REVDAT 1 15-JUL-08 3BEA 0 JRNL AUTH H.HUANG,D.A.HUTTA,H.HU,R.L.DESJARLAIS,C.SCHUBERT, JRNL AUTH 2 I.P.PETROUNIA,M.A.CHAIKIN,C.L.MANTHEY,M.R.PLAYER JRNL TITL DESIGN AND SYNTHESIS OF A PYRIDO[2,3-D]PYRIMIDIN-5-ONE CLASS JRNL TITL 2 OF ANTI-INFLAMMATORY FMS INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 2355 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18342505 JRNL DOI 10.1016/J.BMCL.2008.02.070 REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2313407.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.2 REMARK 3 NUMBER OF REFLECTIONS : 20630 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1514 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 24175 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.02 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 49.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1860 REMARK 3 BIN R VALUE (WORKING SET) : 0.2200 REMARK 3 BIN FREE R VALUE : 0.2490 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 125 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2461 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 169 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.18000 REMARK 3 B22 (A**2) : -3.18000 REMARK 3 B33 (A**2) : 6.36000 REMARK 3 B12 (A**2) : -0.69000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.15 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.680 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.560 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.490 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.110 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.050 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 45.87 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : INH.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : INH.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BEA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000045411. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20630 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 31.130 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.9 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 52.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.23000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX 2005 REMARK 200 STARTING MODEL: PDB ENTRY 2I1M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM ACETATE, LI2SO4, PH REMARK 280 5.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.57000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.42310 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 48.55000 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 40.57000 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 23.42310 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.55000 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 40.57000 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 23.42310 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.55000 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 46.84620 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 97.10000 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 46.84620 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 97.10000 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 46.84620 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 97.10000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1079 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 535 REMARK 465 VAL A 536 REMARK 465 ASP A 537 REMARK 465 TYR A 538 REMARK 465 LYS A 539 REMARK 465 TYR A 540 REMARK 465 LYS A 541 REMARK 465 GLN A 542 REMARK 465 LYS A 543 REMARK 465 PRO A 544 REMARK 465 LYS A 545 REMARK 465 TYR A 546 REMARK 465 GLU A 683 REMARK 465 THR A 684 REMARK 465 ASP A 685 REMARK 465 PRO A 686 REMARK 465 ALA A 687 REMARK 465 PHE A 688 REMARK 465 ALA A 689 REMARK 465 ILE A 690 REMARK 465 ALA A 691 REMARK 465 ASN A 692 REMARK 465 ASP A 922 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 557 15.28 54.25 REMARK 500 LEU A 569 78.23 49.92 REMARK 500 PRO A 570 -159.42 -57.70 REMARK 500 GLU A 573 4.57 -65.84 REMARK 500 ASP A 608 52.66 33.55 REMARK 500 HIS A 623 -151.73 -107.49 REMARK 500 VAL A 681 -99.64 -76.75 REMARK 500 ASP A 778 45.57 -150.36 REMARK 500 THR A 787 -163.78 -112.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IXH A 923 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I0V RELATED DB: PDB REMARK 900 AUTOINHIBITED FORM, COMPLEXED WITH QUINOLONE INHIBITOR REMARK 900 RELATED ID: 2I1M RELATED DB: PDB REMARK 900 AUTOINHIBITED FORM, COMPLEXED WITH ARYLAMIDE INHIBITOR REMARK 900 RELATED ID: 2I0Y RELATED DB: PDB REMARK 900 AUTOINHIBITED FORM, COMPLEXED WITH ARYLAMIDE INHIBITOR REMARK 900 RELATED ID: 2OGV RELATED DB: PDB REMARK 900 AUTOINHIBITED FORM, APO DBREF 3BEA A 538 678 UNP P07333 CSF1R_HUMAN 538 678 DBREF 3BEA A 679 697 UNP Q02763 TIE2_HUMAN 917 935 DBREF 3BEA A 753 922 UNP P07333 CSF1R_HUMAN 753 922 SEQADV 3BEA GLY A 535 UNP P07333 EXPRESSION TAG SEQADV 3BEA VAL A 536 UNP P07333 EXPRESSION TAG SEQADV 3BEA ASP A 537 UNP P07333 EXPRESSION TAG SEQADV 3BEA LEU A 695 UNP Q02763 ALA 933 ENGINEERED MUTATION SEQRES 1 A 333 GLY VAL ASP TYR LYS TYR LYS GLN LYS PRO LYS TYR GLN SEQRES 2 A 333 VAL ARG TRP LYS ILE ILE GLU SER TYR GLU GLY ASN SER SEQRES 3 A 333 TYR THR PHE ILE ASP PRO THR GLN LEU PRO TYR ASN GLU SEQRES 4 A 333 LYS TRP GLU PHE PRO ARG ASN ASN LEU GLN PHE GLY LYS SEQRES 5 A 333 THR LEU GLY ALA GLY ALA PHE GLY LYS VAL VAL GLU ALA SEQRES 6 A 333 THR ALA PHE GLY LEU GLY LYS GLU ASP ALA VAL LEU LYS SEQRES 7 A 333 VAL ALA VAL LYS MET LEU LYS SER THR ALA HIS ALA ASP SEQRES 8 A 333 GLU LYS GLU ALA LEU MET SER GLU LEU LYS ILE MET SER SEQRES 9 A 333 HIS LEU GLY GLN HIS GLU ASN ILE VAL ASN LEU LEU GLY SEQRES 10 A 333 ALA CYS THR HIS GLY GLY PRO VAL LEU VAL ILE THR GLU SEQRES 11 A 333 TYR CYS CYS TYR GLY ASP LEU LEU ASN PHE LEU ARG ARG SEQRES 12 A 333 LYS SER ARG VAL LEU GLU THR ASP PRO ALA PHE ALA ILE SEQRES 13 A 333 ALA ASN SER THR LEU SER THR ARG ASP LEU LEU HIS PHE SEQRES 14 A 333 SER SER GLN VAL ALA GLN GLY MET ALA PHE LEU ALA SER SEQRES 15 A 333 LYS ASN CYS ILE HIS ARG ASP VAL ALA ALA ARG ASN VAL SEQRES 16 A 333 LEU LEU THR ASN GLY HIS VAL ALA LYS ILE GLY ASP PHE SEQRES 17 A 333 GLY LEU ALA ARG ASP ILE MET ASN ASP SER ASN TYR ILE SEQRES 18 A 333 VAL LYS GLY ASN ALA ARG LEU PRO VAL LYS TRP MET ALA SEQRES 19 A 333 PRO GLU SER ILE PHE ASP CYS VAL TYR THR VAL GLN SER SEQRES 20 A 333 ASP VAL TRP SER TYR GLY ILE LEU LEU TRP GLU ILE PHE SEQRES 21 A 333 SER LEU GLY LEU ASN PRO TYR PRO GLY ILE LEU VAL ASN SEQRES 22 A 333 SER LYS PHE TYR LYS LEU VAL LYS ASP GLY TYR GLN MET SEQRES 23 A 333 ALA GLN PRO ALA PHE ALA PRO LYS ASN ILE TYR SER ILE SEQRES 24 A 333 MET GLN ALA CYS TRP ALA LEU GLU PRO THR HIS ARG PRO SEQRES 25 A 333 THR PHE GLN GLN ILE CYS SER PHE LEU GLN GLU GLN ALA SEQRES 26 A 333 GLN GLU ASP ARG ARG GLU ARG ASP HET SO4 A 1 5 HET SO4 A 2 5 HET SO4 A 4 5 HET IXH A 923 38 HETNAM SO4 SULFATE ION HETNAM IXH 8-(2,3-DIHYDRO-1H-INDEN-5-YL)-2-({4-[(3R,5S)-3,5- HETNAM 2 IXH DIMETHYLPIPERAZIN-1-YL]PHENYL}AMINO)-5-OXO-5,8- HETNAM 3 IXH DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE FORMUL 2 SO4 3(O4 S 2-) FORMUL 5 IXH C29 H31 N7 O2 FORMUL 6 HOH *169(H2 O) HELIX 1 1 ASN A 572 GLU A 576 5 5 HELIX 2 2 PRO A 578 ASN A 580 5 3 HELIX 3 3 HIS A 623 GLY A 641 1 19 HELIX 4 4 LEU A 671 SER A 679 1 9 HELIX 5 5 SER A 696 LYS A 772 1 22 HELIX 6 6 ALA A 780 ARG A 782 5 3 HELIX 7 7 ASN A 788 HIS A 790 5 3 HELIX 8 8 PHE A 797 ARG A 801 5 5 HELIX 9 9 ASP A 802 ASP A 806 5 5 HELIX 10 10 PRO A 818 MET A 822 5 5 HELIX 11 11 ALA A 823 ASP A 829 1 7 HELIX 12 12 THR A 833 SER A 850 1 18 HELIX 13 13 ASN A 862 ASP A 871 1 10 HELIX 14 14 PRO A 882 TRP A 893 1 12 HELIX 15 15 GLU A 896 ARG A 900 5 5 HELIX 16 16 THR A 902 ARG A 921 1 20 SHEET 1 A 2 LYS A 551 ILE A 552 0 SHEET 2 A 2 CYS A 774 ILE A 775 -1 O ILE A 775 N LYS A 551 SHEET 1 B 5 LEU A 582 ALA A 590 0 SHEET 2 B 5 GLY A 594 LEU A 604 -1 O GLU A 598 N GLY A 585 SHEET 3 B 5 ALA A 609 LEU A 618 -1 O VAL A 615 N VAL A 597 SHEET 4 B 5 LEU A 660 GLU A 664 -1 O THR A 663 N ALA A 614 SHEET 5 B 5 LEU A 649 CYS A 653 -1 N LEU A 650 O ILE A 662 SHEET 1 C 3 GLY A 669 ASP A 670 0 SHEET 2 C 3 VAL A 784 LEU A 786 -1 O LEU A 786 N GLY A 669 SHEET 3 C 3 ALA A 792 ILE A 794 -1 O LYS A 793 N LEU A 785 SHEET 1 D 2 ILE A 810 LYS A 812 0 SHEET 2 D 2 ALA A 815 LEU A 817 -1 O LEU A 817 N ILE A 810 SITE 1 AC1 3 ARG A 549 LYS A 551 ARG A 777 SITE 1 AC2 5 ARG A 676 ASN A 808 ASN A 854 HOH A 929 SITE 2 AC2 5 HOH A1086 SITE 1 AC3 6 LYS A 595 LYS A 619 SER A 620 GLN A 877 SITE 2 AC3 6 PRO A 882 LYS A 883 SITE 1 AC4 18 LEU A 588 GLY A 589 ALA A 614 LYS A 616 SITE 2 AC4 18 THR A 663 GLU A 664 TYR A 665 CYS A 666 SITE 3 AC4 18 GLY A 669 ASN A 673 SER A 679 LEU A 785 SITE 4 AC4 18 ASP A 796 PHE A 797 ALA A 800 ARG A 801 SITE 5 AC4 18 HOH A 938 HOH A 980 CRYST1 81.140 81.140 145.650 90.00 90.00 120.00 H 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012324 0.007115 0.000000 0.00000 SCALE2 0.000000 0.014231 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006866 0.00000